Enliven Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 05/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 05/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$32 | −$24 | −$20 | −$25 | −$29 | −$23 | −$20 | −$23 | |
| −$0.49 | −$0.38 | −$0.32 | −$0.49 | −$0.57 | −$0.48 | −$0.41 | −$0.54 | |
| 66 | 63 | 62 | 52 | 50 | 48 | 48 | 42 |
Trend